S. Pedersen (Kolding, Denmark), K. Malmstrom (Helsinki, Finland)
Effect of ciclesonide and fluticasone propionate on lower leg growth rate and cortisol excretion in prepubertal children with mild asthma in a placebo-controlled study
L. Agertoft, S. Pedersen (Kolding, Denmark)
|  |
Comparison of ciclesonide once daily (80 μg/d, 160 μg/d) and fluticasone propionate twice daily (176 μg/d) in the treatment of children with persistent asthma
S. Pedersen, A. A. Cruz, J. Fiterman, L. Barkai, S. Hirsch, R. Engelstätter (Kolding, Denmark; Salvador, Porto Alegre, Brazil; Miskolc, Hungary; Konstanz, Germany)
| |
Growth deceleration of children on inhaled corticosteroids is compensated for after the first 12 months of treatment
M. B. Anthracopoulos, A. Papadimitriou, D. B. Panagiotakos, G. Syridou, E. Giannakopoulou, A. Fretzayas, P. Nicolaidou, K. N. Priftis (Rio, Patras, Athens, P. Penteli, Athens, Greece)
|  |
Efficacy and safety of ciclesonide compared with fluticasone propionate or budesonide in adolescent patients with persistent asthma
S. Pedersen, J. H. Vermeulen, H. Magnussen, R. Engelstätter (Kolding, Denmark; Cape Town, South Africa; Grosshansdorf, Konstanz, Germany)
| |
Salmeterol and fluticasone in pre-school children with newly-diagnosed asthma
M. Mäkelä, P. Malmberg, P. Csonka, T. Klemola, M. Kajosaari, A. Pelkonen (Helsinki, Tampere, Espoo, Finland)
| |
Effects of the changing from chlorofluorocarbon (CFC)- beclomethasone dipropionate (BDP) to hydrofluoroalkane (HFA)-BDP on pulmonary function in asthmatic children
Y. Yoshida, T. Inoue, T. Nishikido, M. Kameda, I. Takamatu, S. Doi (Osaka, Japan)
| |
Montelukast: better option in childhood asthma and boon for associated tonsillitis
N. Mishra, K. V. R. Rao, R. N. Samal (Berhampur, Ganjam, Orissa, India)
| |
Effect of montelukast treatment and withdrawal on exhaled nitric oxide and lung function in atopic asthmatic children
P. Montuschi, C. Mondino, P. Koch, G. Baviera (Rome, Italy)
| |
Effect of fluticasone and montelukast in school children with asthma
S. Kamenov, A. Kamenov, B. Kamenov (Nis, Serbia And Montenegro)
| |
Morning cortizolemia and bone status during long term therapy with inhaled steroids in children
P. Chereches-Panta, M. V. Nanulescu, M. Farcau, M. D. Marshall, H. Bolosiu (Cluj-Napoca, Romania)
| |
Young children with asthma treated with budesonide inhalation suspension can successfully be transitioned to once-daily budesonide dry powder inhaler
K. Murphy (Omaha, NE, United States Of America)
| |
Effects on the respirable dose < 3.3 µm of an isotonic DSCG inhalation solution (IsoCROM) comparing different nebuliser systems mimicking 3 year old childrens' breathing patterns
M. Keller, A. Bucholski, M. Hug (Munich, Germany)
| |
The efficacy and safety formoterol-HFA pMDI in school children with persistent asthma
A. Kamenov, S. Kamenov, B. Kamenov (Nis, Serbia And Montenegro)
| |
Effect of inhaled corticosteroid fluticasone propionate on linear growth in preschool children with asthma
I. Mihatov Stefanovic, E. Verona (Zagreb, Croatia)
| |
Comparison of FENO reduction in asthmatic children treated with inhaled budesonide-MDI with two-valved, non valved, or home-made spacers
J. M. Figueroa, C. Velasco Suarez, M. Roque, V. Badaracco, A. M. Balanzat (Buenos Aires, Argentina)
| |
Post-hoc analysis of the effect of montelukast in treating post-RSV-bronchiolitic respiratory symptoms in children
T. Reiss, B. Knorr, J. L. Marchal, M. P. Malice, H. Bisgaard (Rahway, NJ, United States Of America; Copenhagen, Denmark)
| |
The effect of inhaled and/or systemic corticosteroids on bone metabolism in asthmatic children
P. Panaghiotopoulou-Gartagani, I. Voskaki, V. Miligkos, E. Athanasopoulou, E. Georgakopoulou, D. Dimitriou-Papavassiliou, A. Xypolita Zachariadi, G. Chrousos (Athens, Greece)
| |
Safety of montelukast in children with post-RSV-bronchiolitic respiratory symptoms
T. Reiss, B. Knorr, R. Massaad, S. Lu, K. Newcomb, H. Bisgaard (Rahway, NJ, United States Of America; Copenhagen, Denmark)
| |
Induced sputum in children with intermitent and persistent asthma: the effect to treatment
I. C. Sosa, M. Nanulescu, D. Homorodean (Cluj Napoca, Romania)
| |